About the Firm Portfolio Companies News & Events Contact Us   Home

04/03/2007 Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis     03/20/2007 Houston Technology Center Announces $2 Million Award to PLx Pharma Inc., $794,520 Award to Molecular LogiX Inc. by the Texas Emerging Technology Fund     03/19/2007 Opexa Reports Year End 2006 Financial Results     03/01/2007 Kryptiq Applauds Steps to Improve Healthcare Efficiency and Patient–Centered Care     02/14/2007 Opexa Therapeutics Launches Tovaxin™ Clinical Trial Website for Multiple Sclerosis